surpass-cvot tirzepatide trial: was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: https://t.co/6VQpBHFP2I Tirzepatide for diabetes: on track
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15





















![Glutathione Peroxidase 3/GPX3 Antibody [Unconjugated]](https://images.novusbio.com/images/af4199_human-mouse-rat-glutathione-peroxidase-3-affinity-purif-pab-immunohistochemistry-12122025932593.jpg)





